THE CONTROL OF insulin secretion is a multifactorial and highly interconnected process involving nutritional and nonnutritional factors. Glucose stimulates insulin secretion by an increase in the cytosolic ratio of ATP to ADP, which inhibits ATP-sensitive K ϩ channels (K ATP channels), thereby causing membrane depolarization, activation of voltage-sensitive Ca 2ϩ influx, and a rise in the cytosolic free Ca 2ϩ concentration ([Ca 2ϩ ] i ) that triggers insulin secretion (19, 22, 38) . In addition, glucose further augments insulin secretion by a K ATP channelindependent pathway, i.e., by enhancing the stimulatory effect of Ca 2ϩ on the secretory process (7, 29, 38) . Neurotransmitters and hormones that activate the Ca 2ϩ -phosphoinositide (PI) pathway potentiate glucoseinduced insulin release and thus may be of major relevance to the regulation of insulin secretion (27, 38, 40) . ACh, arginine vasopressin (AVP), and bombesin, which activate the Ca 2ϩ -PI signaling pathway, cause a rise in [Ca 2ϩ ] i and stimulate insulin secretion from both normal and transformed ␤-cells (6, 14, 17, 24, 25, 27, 30, 32, 34, 40) . The generation of Ca 2ϩ signals by phospholipase C (PLC)-linked hormones requires inositol 1,4,5-trisphosphate (IP 3 )-linked mobilization of Ca 2ϩ from intracellular stores and voltage-sensitive and -insensitive Ca 2ϩ influx from the outside (17, 30, 32) . The actions of PLC-linked agonists on [Ca 2ϩ ] i and on insulin secretion are glucose dependent, further demonstrating the interactive regulation of insulin secretion (10, 18, 27, 40) . Sulfonylurea drugs, which are widely used drugs in the treatment of non-insulin-dependent diabetes mellitus, and diazoxide, which has been used for many years to control hypoglycemia caused by inappropriate insulin secretion, modulate insulin release by regulating K ATP channel activity (23) . Sulfonylureas, which much like a rise in extracellular glucose, inhibit K ATP channels and cause membrane depolarization, activation of voltage-sensitive Ca 2ϩ influx, and a rise in [Ca 2ϩ ] i that initiates insulin release (3, 23, 33) . Diazoxide, by contrast, activates K ATP channels, thereby causing membrane hyperpolarization, inhibition of Ca 2ϩ influx through voltage-sensitive Ca 2ϩ channels (VSCC), and inhibition of insulin secretion (3, 23, 33) . Thus control of insulin release by sulfonylureas or diazoxide is thought to be mainly caused by its own regulatory actions on K ATP channels and by augmenting or opposing the effects of glucose on K ATP channel activity. However, given the pivotal role of K ATP channels in determining the membrane potential and thereby controling voltagesensitive Ca 2ϩ influx in ␤-cells, sulfonylurea-or diazoxideinduced modulation of K ATP channel activity may also interact with the intracellular Ca 2ϩ signal evoked by PLC-linked hormones, thereby regulating insulin release in response to these agonists. This may be relevant to our understanding of the pharmacological actions of sulfonylureas and diazoxide, and the role of K ATP channels in PLC-linked control of ␤-cell function, and may elucidate some of the mechanisms underlying the glucose dependency of PLC-linked Ca 2ϩ signaling and insulin secretion. In the present study, we therefore investigated the effects of tolbutamide and diazoxide on the cytosolic Ca 2ϩ signal and insulin secretion evoked by the PLC-linked agonists AVP and bombesin and the ACh analog carbachol. [Ca 2ϩ ] i was measured in single fura 2-loaded HIT-T15 and normal mouse ␤-cells. Insulin release was determined from cell populations of HIT-T15 cells that respond to various secretagogues, including glucose (12, 28) .
MATERIALS AND METHODS
HIT-T15 cell culture. The HIT-T15 cells were kindly provided by Dr. W. Knepel (Göttingen, Germany). The cells were grown in RPMI 1640 medium containing 10 mM glucose supplemented with 10% FCS (vol/vol), 100 units of penicillin/ ml, and 100 µg streptomycin/ml at 37°C in 5% CO 2 and 95% air (vol/vol). All experiments were performed with cells from passage 65 to 86.
Preparation of islet ␤-cells. NMRI mice were housed in a temperature-controlled room with a 12:12-h light-dark cycle and had ad libitum access to standard chow and water. They were treated in accordance with all guidelines and regulations of our institutional animal care and use committee. The islets of Langerhans were isolated from female NMRI mice aged 8-12 wk by collagenase digestion. To obtain dispersed cells, islets were incubated for 10 min in Ca 2ϩ -free medium [135 mM NaCl, 5.6 mM KCl, 1.2 mM MgCl 2 , 3 mM glucose, 10 mM NaHEPES, 100 units of penicillin/ml, 100 µg streptomycin/ml, and 1% BSA (wt/vol) gassed with 100% O 2 (vol/vol), pH 7.4] with gentle pipetting through a siliconized glass pipette until the islets disappeared. Islet cells were washed, resuspended in RPMI 1640 medium containing 5.5 mM glucose supplemented with 10% FCS (vol/vol), 100 units of penicillin/ ml, and 100 µg streptomycin/ml, allowed to attach to glass coverslips, and maintained in a short culture for up to 2 days at 37°C in 5% CO 2 and 95% air (vol/vol).
Measurement of [Ca 2ϩ ] i . HIT-T15 cells or primary islet cells subcultured on coverslips were loaded with 5 µM fura 2-AM for 30 min at 37°C in medium containing 130 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 1.5 mM CaCl 2 , 10 mM glucose, 20 mM HEPES, 2% BSA (wt/vol), and 0.1% Pluronic F-127 (wt/vol) gassed with 100% O 2 (vol/vol), pH 7.4. After being loaded, the coverslips were washed, mounted in a temperature-controlled superfusion chamber (37°C), and placed on the stage of a Zeiss Axiovert IM 135 equipped with a ϫ40 Achrostigmat oil immersion objective (Zeiss, Jena, Germany). The chamber was superfused with the same buffer as that used for measuring insulin release at a flow rate of 0.75 ml/min. Ca 2ϩ measurements were done on cells of average size and healthy appearance (round in shape, no membrane blebs). Fura 2 fluorescence from a single cell was recorded with a dual excitation spectrofluorometer system (Deltascan 4000; Photon Technology Instruments, Wedel, Germany).
[Ca 2ϩ ] i were calculated according to the formula [Ca 2ϩ 
, where R is the ratio of fluorescence, and the dissociation constant (K d ) ϭ 225 nM (9) . The ratio at saturating Ca 2ϩ concentration (R max ), the ratio of fluorescence at zero Ca 2ϩ (R min ), and the ratio of the fluorescence intensity at 380 nm at zero and saturated Ca 2ϩ concentrations (B) are constants that were determined in the superfusion chamber from solutions containing fura 2-free acid (1 µM) and various concentrations of free Ca 2ϩ (data not shown). All records have been corrected for autofluorescence of unloaded cells at each wavelength before the ratio was used.
Insulin secretion. HIT-T15 cells were subcultured in sixwell plates at a density of 2 ϫ 10 6 cells/well. After 2 days, the culture medium was removed, and the cells were washed with medium containing 130 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 1.5 mM CaCl 2 , 10 mM glucose, 20 mM HEPES, and 0.1% BSA (wt/vol) gassed with 100% O 2 (vol/vol), pH 7.4. The cells were then preincubated for 1 h with or without glucose (10 mM) and were washed again, and fresh medium (2 ml) was added with the respective test agents. After 15 min, the supernatant was removed, and the insulin concentration was measured by RIA using a commercial kit (Kabi Diagnostics Pharmacia, Uppsala, Sweden). During the experiments, the cells were kept at 37°C.
Materials. Fura 2-AM and Pluronic F-127 were purchased from Molecular Probes (Eugene, OR), RPMI 1640, penicillin, and streptomycin were from Life Technologies (Berlin, Germany), collagenase was from Boehringer (Mannheim, Germany), thapsigargin was from Calbiochem (Bad Soden, Germany), and AVP and the other substances were from Sigma Chemical (Munich, Germany). Nifedipine and BAY K 8544 were provided by Bayer (Leverkusen, Germany). Stock solutions were prepared in water or as follows: AVP (100 µM) in 0.01 M HCl, tolbutamide (30 mM) in 150 mM NaOH, diazoxide (10 mM) and thapsigargin (5 mM) in DMSO, nifedipine and BAY K 8644 (5 mM) in ethanol.
Statistics. Unless representative tracings are shown, values are means Ϯ SE. Statistical analysis was performed using Student's t-test for paired or unpaired data when two samples were compared. Multiple comparisons were assessed by ANOVA followed by the Student-Newman-Keuls test. P Ͻ 0.05 was considered as significantly different. (Fig. 1E ) while in the remaining three cells tolbutamide up to a concentration of 300 µM was without any effect (Fig. 1F ). In cells that had been pretreated for 30-60 min in glucose-free medium, tolbutamide (30 µM) caused a plateau-like increase in [Ca 2ϩ ] i by 65 Ϯ 13 nM (n ϭ 6 of 10 cells).
RESULTS

Effects of tolbutamide and diazoxide on PLC-linked
Mechanisms of the tolbutamide-and diazoxideinduced changes of PLC-linked Ca 2ϩ signals in HIT-T15
cells. The effects of tolbutamide and diazoxide on the PLC-linked Ca 2ϩ transients could be mimicked by the VSCC agonist BAY K 8644 and the VSCC antagonist verapamil, respectively (Fig. 2, A and B) . BAY K 8644 (1 µM) reversibly increased the frequency and amplitude of the PLC-linked Ca 2ϩ transients and led to a plateau-like rise in [Ca 2ϩ ] i in six of six cells. Verapamil (50 µM) either reduced the frequency and/or amplitude of the AVP-and bombesin-induced Ca 2ϩ transients in 10 of 18 cells by 55 Ϯ 16 and 18 Ϯ 9%, respectively, or stopped them in 8 of 18 cells. In addition, verapamil (50 µM) inhibited the tolbutamide-induced enhancement of the PLC-linked Ca 2ϩ transients in three of three cells (Fig. 2C) . In Ca 2ϩ -free medium, AVP caused one or two was 101 Ϯ 5 nM (n ϭ 32) in the presence of glucose (6 mM). Carbachol (3 µM), which stimulates muscarinic receptors coupled to the Ca 2ϩ -PI signaling pathway, elicited a biphasic rise in [Ca 2ϩ ] i with an initial peak followed by a sustained plateau in most cells (Fig. 3) . In some cells, however, repetitive Ca 2ϩ transients were observed in response to carbachol (3 µM; data not shown). Carbachol (3 µM) increased [Ca 2ϩ ] i by 327 Ϯ 47 and 58 Ϯ 14 nM at its peak or plateau (measured after 5 min), respectively (n ϭ 18). Reexposure of cells to carbachol (3 µM) after a washout period of 30 min caused a nearly identical Ca 2ϩ response (96 Ϯ 4% of the initial peak and plateau; n ϭ 9; Fig. 3A) . To assess the effect of tolbutamide on the carbachol-induced Ca 2ϩ signal, tolbutamide (1 µM) was added to the perfusion medium 5 min before the second stimulation with carbachol (3 µM). Tolbutamide (100 µM) caused no changes in [Ca 2ϩ ] i in the presence of glucose (6 mM). Pretreatment for 5 min with diazoxide (100 µM) reduced the carbachol (3 µM)-induced peak increase and plateau rise in [Ca 2ϩ ] i by 69 Ϯ 13 and 68 Ϯ 18% (n ϭ 4; P Ͻ 0.02; Fig. 3E ), respectively, when compared with the control stimulation in the same cell. Preincubation of mouse ␤-cells for 30-60 min in glucosefree medium reduced basal [Ca 2ϩ ] i to 86 Ϯ 3 nM (n ϭ 11). Under these glucose-free conditions, the carbachol (3 µM)-induced Ca 2ϩ response was much smaller than in the presence of glucose (6 mM) and amounted to 33 Ϯ 10 and 10 Ϯ 4 nM at its peak or plateau, respectively (n ϭ 11; Fig. 3B ). Pretreatment with tolbutamide (10 µM) for 5 min, which by itself caused no changes in [Ca 2ϩ ] i , significantly enhanced the Ca 2ϩ signal evoked by a second stimulation with carbachol (3 µM) in the same cells (Fig. 3B) . The carbachol (3 µM)-induced peak Ca 2ϩ response was 123 Ϯ 54 nM, and the plateau rise was 46 Ϯ 31 nM (n ϭ 4; P Ͻ 0.05).
Mechanisms of the tolbutamide-and diazoxideinduced changes of PLC-linked Ca 2ϩ signals in mouse
␤-cells. The effects of tolbutamide and diazoxide on the carbachol (3 µM)-induced increase in [Ca 2ϩ ] i in 6 mM glucose could be mimicked by BAY K 8644 and the VSCC antagonist nifedipine (Fig. 3, D and F) . BAY K 8644 (1 µM), which caused a small rise in [Ca 2ϩ ] i by 6 Ϯ 2 nM (n ϭ 7) in 6 mM glucose, increased the carbachol (3 µM)-induced peak increase and plateau rise in [Ca 2ϩ ] i to 421 Ϯ 127 and 515 Ϯ 154% of the control stimulation (n ϭ 7; P Ͻ 0.05; Fig. 3D ). Nifedipine (10 µM), which like diazoxide (100 µM) had no effect on [Ca 2ϩ ] i in the presence of glucose (6 mM), inhibited the carbachol (3 µM)-induced peak increase and plateau rise in [Ca 2ϩ ] i by 61 Ϯ 12 and 42 Ϯ 22% (n ϭ 8; P Ͻ 0.05; Fig. 3F ), respectively. As shown in Table 2 , neither tolbutamide (30 µM) nor diazoxide (100 µM) affected the carbachol (10 µM)-induced Ca 2ϩ signal in Ca 2ϩ -free medium or the thapsigargin (2 µM)-induced Ca 2ϩ influx through non-L-type Ca 2ϩ channels.
Effects of tolbutamide and diazoxide on PLC-linked insulin secretion from HIT-T15 cells.
In the presence of glucose (10 mM), insulin secretion was 46 Ϯ 5 µU/ml (n ϭ 24) during 15 min static incubation from populations of HIT-T15 cells and was enhanced by tolbutamide (30 µM), AVP (1 nM), and bombesin (100 pM; Fig.  4A ). When tolbutamide (30 µM) and AVP (1 nM) or bombesin (100 pM) were added together, the insulin secretory response to the combined agonists was greater than additive (Fig. 4A) . Diazoxide (30 µM) inhibited insulin release in the presence of glucose (10 mM) by 20 Ϯ 9% (n ϭ 12; data not significant) and diminished the AVP (1 nM)-and bombesin (100 pM)-induced insulin secretion (Fig. 4A) . Nifedipine (10 µM) reduced insulin secretion in the presence of glucose (10 mM) by 32 Ϯ 4% (n ϭ 16; P Ͻ 0.05) and inhibited AVP-induced insulin secretion by 39 Ϯ 2% (n ϭ 24; P Ͻ 0.001). Neither tolbutamide (30 µM) nor diazoxide (30 µM) affected basal insulin secretion or AVP-stimulated insulin secretion in the presence of nifedipine (10 µM), as depicted in Fig. 4B . When HIT-T15 cells had been preincubated for 60 min in glucose-free medium and were kept at zero glucose during the static incubation period, insulin release amounted to 35 Ϯ 5 µU/ml (n ϭ 12), which was somewhat but not significantly lower than in the presence of glucose (10 mM). Stimulation with glucose (10 mM) for 15 min in HIT-T15 cells that had previously been kept in zero glucose for 30-60 min resulted in a significant increase in insulin secretion from 31 Ϯ 2 µU/ml (n ϭ 29) to 51 Ϯ 4 µU/ml (n ϭ 23, P Ͻ 0.009), demonstrating that the HIT-T15 cells used are responsive to glucose. Under glucose-free conditions, the stimulation of insulin release by tolbutamide (30 µM) and AVP (1 nM) was significantly reduced (Fig. 4C) . However, insulin secretion in response to the combination of tolbutamide (30 µM) and AVP (1 nM) was again greater than additive, although the overall secretory response was lower than in experiments carried out in the presence of 10 mM glucose (Fig. 4A) . In the absence of glucose, diazoxide (30 µM) neither affected basal nor AVP (1 nM)-induced insulin secretion from HIT-T15 cells (Fig. 4C) .
DISCUSSION
In the present study, we demonstrate that tolbutamide and diazoxide, which close and open K ATP channels, respectively, critically regulate PLC-linked Ca 2ϩ signaling in clonal HIT-T15 and primary mouse ␤-cells. In HIT-T15 cells, tolbutamide caused a concentrationdependent increase in the frequency of the AVP-or bombesin-induced Ca 2ϩ transients in the presence of high extracellular glucose (10 mM). At intermediate or high concentrations of tolbutamide (30 and 300 µM), the oscillatory Ca 2ϩ signal switched to a plateau-like rise in [Ca 2ϩ ] i . Conversely, diazoxide, which activates K ATP channels, reduced the frequency and sometimes the amplitude of the Ca 2ϩ transients and stopped them completely in some cells, as described previously (16) . Qualitatively similar results were obtained in mouse ␤-cells where in the presence of glucose (6 mM) tolbutamide and diazoxide potentiated or inhibited the carbachol-induced biphasic increase in [Ca 2ϩ ] i , respectively. Because BAY K 8644, which increases the open probability of L-type VSCC, and the L-type VSCC antagonists verapamil and nifedipine mimicked the actions of tolbutamide and diazoxide, respectively, their effects on PLC-linked Ca 2ϩ signals could be explained by modulation of voltage-sensitive Ca 2ϩ influx.
In the presence of elevated glucose, PLC-linked agonists by themselves cause membrane depolarization and activation of Ca 2ϩ influx through VSCC, which is necessary for the sustained generation of PLC-linked Ca 2ϩ signals in ␤-cells, as demonstrated by the actions of the VSCC blockers in this study and as reported previously (16, (30) (31) (32) . However, the mechanisms, underlying the depolarizing action of PLC-linked agonists in ␤-cells are incompletely understood. In RINm5F cells, AVP causes membrane depolarization directly (21) , and activation of protein kinase C has been shown to cause membrane depolarization by closure of K ATP channels (37) . In HIT-T15 cells and in normal mouse ␤-cells, no such direct effects of PLC-linked agonists on K ATP channels have been reported (6, 13) . It rather appears that emptying of intracellular Ca 2ϩ stores activates a depolarizing current, which enhances Ca 2ϩ influx through VSCC in ␤-cells (39) . In addition, PLClinked agonists may inhibit Ca 2ϩ -activated K ϩ channels, thereby augmenting glucose-induced electrical activity and voltage-sensitive Ca 2ϩ influx (36) . Tolbutamide and diazoxide, by modulating K ATP channel activity, may therefore indirectly enhance or oppose the depolarizing mechanisms activated by PLC-linked agonists, thereby tuning voltage-sensitive Ca 2ϩ influx activated by PLC-linked agonists.
The mechanisms by which Ca 2ϩ influx through VSCC could modulate PLC-linked Ca 2ϩ signals are yet unclear but may involve modulation of IP 3 -production and/or the IP 3 -linked Ca 2ϩ release process (1, 2) . This can even occur without changing the average [Ca 2ϩ ] i as observed here where the changes in PLC-linked Ca 2ϩ signals caused by the addition of tolbutamide or diazoxide were not usually accompanied by concomitant changes in baseline Ca 2ϩ . Rather, such limited Ca 2ϩ influx may cause local changes of Ca 2ϩ at the microdomains adjacent to the Ca 2ϩ regulatory sites of the IP 3 receptor, thereby determining the threshold for IP 3 -mediated Ca 2ϩ release (8) . Such a mechanism could well explain the influence of voltage-sensitive Ca 2ϩ influx on PLC-linked Ca 2ϩ transient frequency and Values are means Ϯ SE; n, no. of experiments. Tolbutamide and diazoxide were added 5 min before the respective stimulus and were present throughout the experiment. * P, NS vs. control.
amplitude in HIT-T15 cells and on the carbacholinduced Ca 2ϩ signal in mouse ␤-cells where not only the plateau of the Ca 2ϩ signal, which is dependent on Ca 2ϩ influx from the outside, but also the initial peak, which mainly reflects internal Ca 2ϩ mobilization, is affected by tolbutamide and diazoxide. Evidence for a direct interaction of tolbutamide or diazoxide with IP 3 -induced Ca 2ϩ mobilization could not be found. Likewise, as judged by the actions of thapsigargin in the presence of L-type VSCC blockers, capacitative Ca 2ϩ entry through non-L-type Ca 2ϩ channels, which also contributes to sustained PLC-linked Ca 2ϩ signals in ␤-cells (16, 30, 32) , is not altered by tolbutamide or diazoxide. Thus it appears that tolbutamide and diazoxide regulate PLC-linked Ca 2ϩ signals predominantly if not exclusively by modulating K ATP channel activity, thereby determining membrane potential and voltagesensitive Ca 2ϩ influx.
Physiologically, K ATP channel activity is controlled by the cytosolic ratio of ATP to ADP, which in turn is determined by the ambient glucose concentration. In glucose-free medium, which leads to a decrease in the cytosolic ratio of ATP to ADP, activation of K ATP channels, and membrane hyperpolarization, the frequency and amplitude of AVP-induced Ca 2ϩ transients decreased and finally ceased in HIT-T15 cells, and in mouse ␤-cells the carbachol-induced Ca 2ϩ signal was greatly reduced, confirming the glucose dependency of PLC-linked Ca 2ϩ signaling in ␤-cells (10, 18, 27, 40) . In the absence of glucose, tolbutamide restored AVPinduced Ca 2ϩ transients in some but not all HIT-T15 cells and potentiated the Ca 2ϩ signal elicited by carbachol in mouse ␤-cells. This indicates that glucosedependent membrane predepolarization and facilitation of voltage-sensitive Ca 2ϩ influx, which is required for further membrane depolarization and activation of VSCC by PLC-linked signals (18) , may contribute to the glucose dependency of PLC-linked Ca 2ϩ signals in ␤-cells (10, 18, 27, 40) . However, other sites appear to exist whereby glucose-dependent processes regulate PLC-linked Ca 2ϩ signals. Diazoxide even at high concentrations stopped the Ca 2ϩ transients only in a small subset of cells, and tolbutamide only partly restored the PLC-linked Ca 2ϩ signals in glucose-free medium. Although not tested here, glucose has been shown to enhance production of IP 3 in response to receptor activation (40) and to be a prerequisite for the reuptake of Ca 2ϩ into the IP 3 -sensitive Ca 2ϩ pool (11), thus providing additional mechanisms for the glucose dependency of the effects of PLC-linked agonists on [Ca 2ϩ ] i in ␤-cells.
In HIT-T15 cells, tolbutamide stimulated insulin secretion and potentiated insulin release in response to AVP and bombesin, whereas diazoxide reduced basal insulin release, albeit not significantly, and inhibited PLC-linked insulin secretion in the presence of glucose (10 mM). The actions of tolbutamide and diazoxide on PLC-linked insulin secretion largely paralleled their effects on PLC-linked Ca 2ϩ signaling and were similar to the effects of VSCC activation or inhibition reported previously (31) . This suggests that tolbutamide and diazoxide critically determine insulin secretion in response to PLC-linked hormones by regulating PLClinked Ca 2ϩ signaling through modulation of voltagesensitive Ca 2ϩ influx. Recently, it has been proposed that sulfonylureas and diazoxide, in addition to their actions on K ATP channels, could modulate insulin secre- tion by altering the efficacy of Ca 2ϩ on the exocytotic process (4, 5, 26) . However, such a K ATP channelindependent pathway does not appear to be involved in the actions of tolbutamide or diazoxide on PLC-linked insulin secretion, since in the presence of nifedipine tolbutamide failed to potentiate AVP-induced insulin secretion and diazoxide did not further inhibit AVPinduced insulin secretion. This is consistent with a recent report showing convincingly that both agents influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca 2ϩ in mouse ␤-cells (20) .
In the absence of glucose, insulin release was somewhat lower than from cells chronically exposed to glucose (10 mM), and AVP-induced insulin secretion was largely inhibited, confirming the glucose-dependent action of PLC-linked agonists on insulin secretion both from transformed and normal ␤-cells (40) . This may involve modulation of K ATP channels, since diazoxide inhibited AVP-induced insulin secretion in the presence of glucose (10 mM) to a similar degree and since AVP-induced insulin secretion was potentiated by tolbutamide in the absence of glucose. However, in glucose-free medium, the tolbutamide-induced insulin secretion was lower despite similar effects on [Ca 2ϩ ] i in the presence or absence of glucose, and the combined effect of tolbutamide and AVP on insulin secretion was reduced. This points to additional sites by which glucose could enhance PLC-linked insulin secretion, such as the release process itself (15, 38) .
In summary, we demonstrate here that tolbutamide and diazoxide, by modulating K ATP channel activity and thereby controlling Ca 2ϩ influx through VSCC, critically regulate Ca 2ϩ signaling and insulin secretion elicited by PLC-linked agonists in ␤-cells. This might contribute to the stimulatory and inhibitory actions on insulin secretion by sulfonylureas and diazoxide when used as therapeutic agents. Furthermore, besides their well-accepted role in glucose-mediated Ca 2ϩ signaling and insulin secretion, K ATP channels may be similarly important for the regulation of insulin release in response to neurohumoral signals activating the Ca 2ϩ -PI signaling pathway in ␤-cells. Modulation of K ATP channels appears to be a major mechanism for the glucosedependent action of PLC-linked agonists on [Ca 2ϩ ] i and insulin secretion. This may be important for the integration of metabolic and neurohumoral signals under conditions where the glucose concentration is high and ␤-cells are exposed to PLC-linked stimuli.
